Next Article in Journal
Rho Kinase (ROCK) Inhibitors in the Treatment of Glaucoma and Glaucoma Surgery: A Systematic Review of Early to Late Phase Clinical Trials
Next Article in Special Issue
Comparison of PERCIST5, imPERCIST5, and PERCIMT Criteria for Early Assessment of Pembrolizumab Response with FDG-PET/CT in Metastatic Bladder Cancer Patients
Previous Article in Journal
New Cannabinoids and Chlorin-Type Metabolites from the Flowers of Cannabis sativa L.: A Study on Their Neuroblastoma Activity
Previous Article in Special Issue
Contribution of [18F]FET PET in the Management of Gliomas, from Diagnosis to Follow-Up: A Review
 
 
Review

Article Versions Notes

Pharmaceuticals 2025, 18(4), 522; https://doi.org/10.3390/ph18040522
Action Date Notes Link
article pdf uploaded. 3 April 2025 15:25 CEST Version of Record https://www.mdpi.com/1424-8247/18/4/522/pdf-vor
article xml file uploaded 7 April 2025 11:09 CEST Original file -
article xml uploaded. 7 April 2025 11:09 CEST Update https://www.mdpi.com/1424-8247/18/4/522/xml
article pdf uploaded. 7 April 2025 11:09 CEST Updated version of record https://www.mdpi.com/1424-8247/18/4/522/pdf
article html file updated 7 April 2025 11:11 CEST Original file https://www.mdpi.com/1424-8247/18/4/522/html
Back to TopTop